glp-1 heart failure reduced ejection fraction Receptor Agonists in Therapeutic modalities in heart failure

Eli Lilly has developed tirzepatide, which adds activity of another incretin-like peptide, GIP, to the GLP-1 backbone

22 Key Themes For Inspection-Based Warning Letters Compounding Two compounding pharmacies regulated under section 503A of the FDCA (503A pharmacies) and 10 outsourcing facilities regulated under section 503B of the FDCA (503B facilities) received warning letters in FY25

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

The BALANCE Model launching May 2026 is worth watching

If your pen is already 40 days into its room temperature window, you have less margin than a fresh pen